Working… Menu

Randomized, Placebo-controlled, Observer-blinded Phase 1 Safety and Immunogenicity Study of Inactivated Zika Virus Vaccine Candidate in Healthy Adults

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT03425149
Recruitment Status : Completed
First Posted : February 7, 2018
Last Update Posted : July 5, 2019
Emergent BioSolutions
Information provided by (Responsible Party):
Valneva Austria GmbH

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : June 26, 2018
Actual Study Completion Date : November 16, 2018